Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma
Brief Summary: The purpose of the trial is to evaluate the efficacy and safety of two different doses of QMF149 (QMF149 150/160 µg and QMF149 150/320 µg via Concept1) over two respective MF doses (MF 400 µg and MF 800 µg via Twisthaler® (total daily dose)) in poorly controlled asthmatic participants as determined by pulmonary function testing, and effects on asthma control


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: budesonide | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: formoterol | Intervention Type: DRUG; Name: budesonide/formoterol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: formoterol; Assigned to Arm(s): 3
B: Arm Label: QMF149 150/160 µg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol acetate/Mometasone furoate | Arm Label: QMF149 150/320 µg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol acetate/Mometasone furoate | Arm Label: MF 400 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone furoate | Arm Label: Salmeterol /fluticasone 50/500 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol xinafoate/fluticasone propionate | Arm Label: MF 800 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone furoate | Intervention Type: DRUG; Name: Indacaterol acetate/Mometasone furoate; Assigned to Arm(s): QMF149 150/160 µg, QMF149 150/320 µg | Intervention Type: DRUG; Name: Mometasone furoate; Assigned to Arm(s): MF 400 µg, MF 800 μg | Intervention Type: DRUG; Name: Salmeterol xinafoate/fluticasone propionate; Assigned to Arm(s): Salmeterol /fluticasone 50/500 μg
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Budesonide / formoterol fumarate (SYMBICORT) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Budesonide | Intervention Type: DRUG; Name: Budesonide / formoterol fumarate (SYMBICORT); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Budesonide; Assigned to Arm(s): 2
D: Arm Label: ADVAIR 100/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 100/50mcg | Arm Label: ADVAIR 250/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 250/50mcg | Arm Label: ADVAIR 500/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 500/50mcg | Arm Label: FLOVENT 100mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 100mcg | Arm Label: FLOVENT 250mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 250mcg | Arm Label: FLOVENT 500mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 500mcg | Intervention Type: DRUG; Name: ADVAIR 100/50mcg; Assigned to Arm(s): ADVAIR 100/50mcg | Intervention Type: DRUG; Name: ADVAIR 250/50mcg; Assigned to Arm(s): ADVAIR 250/50mcg | Intervention Type: DRUG; Name: ADVAIR 500/50mcg; Assigned to Arm(s): ADVAIR 500/50mcg | Intervention Type: DRUG; Name: FLOVENT 100mcg; Assigned to Arm(s): FLOVENT 100mcg | Intervention Type: DRUG; Name: FLOVENT 250mcg; Assigned to Arm(s): FLOVENT 250mcg | Intervention Type: DRUG; Name: FLOVENT 500mcg; Assigned to Arm(s): FLOVENT 500mcg

Answer: B